Publicaciones en colaboración con investigadores/as de Helsinki University Central Hospital (14)

2021

  1. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease

    Aging, Vol. 13, Núm. 19, pp. 22690-22709

2017

  1. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study

    Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752

2016

  1. A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

    Targeted Oncology, Vol. 11, Núm. 3, pp. 293-308

  2. Increased burden of cerebral small vessel disease in patients with type 2 diabetes and retinopathy

    Diabetes Care, Vol. 39, Núm. 9, pp. 1614-1620

2013

  1. Bevacizumab plus chemotherapy continued beyond first progression in patients withmetastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

    Annals of Oncology, Vol. 24, Núm. 9, pp. 2342-2349

2012

  1. Candidate driver genes in microsatellite-unstable colorectal cancer

    International Journal of Cancer, Vol. 130, Núm. 7, pp. 1558-1566

2010

  1. Mutations in the circadian gene CLOCK in colorectal cancer

    Molecular Cancer Research, Vol. 8, Núm. 7, pp. 952-960

2008

  1. Unregulated smooth-muscle myosin in human intestinal neoplasia

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 14, pp. 5513-5518

2007

  1. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis

    Oncogene, Vol. 26, Núm. 2, pp. 312-320

2005

  1. 7q deletion mapping and expression profiling in uterine fibroids

    Oncogene, Vol. 24, Núm. 43, pp. 6545-6554

  2. Gene expression signatures for colorectal cancer microsatellite status and HNPCC

    British Journal of Cancer, Vol. 92, Núm. 12, pp. 2240-2248

  3. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

    Gastroenterology, Vol. 129, Núm. 3, pp. 874-884

  4. SMAD4 as a prognostic marker in colorectal cancer

    Clinical Cancer Research, Vol. 11, Núm. 7, pp. 2606-2611

  5. SMAD4 levels and response to 5-fluorouracil in colorectal cancer

    Clinical Cancer Research, Vol. 11, Núm. 17, pp. 6311-6316